IRulya Therapeutics (IRLA) Share-based Compensation (IS) (2024 - 2026)
IRulya Therapeutics' Share-based Compensation (IS) came in at $12.09 million for Q2 2026, up 850.0% from $1.27 million a year earlier and up 840.4% from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Share-based Compensation (IS) (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, IRulya Therapeutics reported Share-based Compensation (IS) of $15.83 million, up 222.4% year-over-year; for FY2025, it was $5.11 million, up 7.6% from FY2024.
- Going back by year, Share-based Compensation (IS) was $4.75 million in FY2024.
- The Q2 2026 figure represents the highest quarterly Share-based Compensation (IS) in data going back to Q2 2024.
- Year-over-year, Share-based Compensation (IS) increased in four of the last five quarters, with growth averaging 172.9%.
- Business Quant data shows IRLA's Share-based Compensation (IS) at $1.29 million (Q1 2026), $1.19 million (Q4 2025) and $1.26 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | - |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | - |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 12.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.09 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.22 Mn |
API Access
IRulya Therapeutics Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();